Loading...
Loading...
Agilent Technologies Inc.
A today announced that it has entered into
an exclusive supply agreement with LipoScience Inc. to provide nuclear
magnetic resonance (NMR) components for LipoScience's Vantera Clinical
Analyzer. The analyzer is the first fully-automated NMR diagnostic platform
designed specifically for the clinical laboratory and cleared by the U.S. Food
and Drug Administration.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in